Systematic switch from Innovator Infliximab to Biosimilar...

  • Main
  • 2017 / 10
  • Systematic switch from Innovator Infliximab to Biosimilar...
Seminars in Arthritis and Rheumatism 2017 / 10

Systematic switch from Innovator Infliximab to Biosimilar Infliximab in Inflammatory Chronic Diseases in Daily Clinical Practice: The Experience of Cochin University Hospital, Paris, France

Avouac, Jérôme, Moltó, Anna, Abitbol, Vered, Etcheto, Adrien, Salcion, Axelle, Gutermann, Loriane, Klotz, Caroline, Elhai, Muriel, Cohen, Pascal, Soret, Pierre Antoine, Morin, Florence, Conort, Ornell
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Seminars in Arthritis and Rheumatism
DOI:
10.1016/j.semarthrit.2017.10.002
Date:
October, 2017
File:
PDF, 824 KB
english, 2017
Conversion to is in progress
Conversion to is failed